Immuron (IMRN) Other Operating Expenses (2016 - 2024)
Immuron's quarterly Other Operating Expenses came in at $374.2 billion in Q4 2024, up 15054537.87% year-on-year from N/an in Q1 2024, and up 15054537.87% quarter-over-quarter from $2.5 million in Q4 2023.
Immuron has reported Other Operating Expenses for 9 years, with the latest figure at $374.2 billion in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses rose 15054537.87% year-over-year to $374.2 billion; the trailing twelve-month figure through Sep 2025 stood at $374.2 billion (up 15054537.87% YoY), and the FY2025 full-year result was $19775.7, up 91.33% from the prior year.
- Other Operating Expenses for Q4 2024 stood at $374.2 billion, up from $2.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $374.2 billion in Q4 2024, with the low at $3139.5 in Q4 2021.
- Average Other Operating Expenses over 5 years is $74.8 billion, with a median of $1.6 million recorded in 2022.
- Year-over-year, Other Operating Expenses slipped 7.78% in 2021 and surged 15054537.87% in 2024.
- Tracing IMRN's Other Operating Expenses over 5 years: stood at $3404.5 in 2020, then retreated by 7.78% to $3139.5 in 2021, then jumped by 51154.0% to $1.6 million in 2022, then surged by 54.46% to $2.5 million in 2023, then surged by 15054537.87% to $374.2 billion in 2024.
- The last three Other Operating Expenses figures came in at $374.2 billion (Q4 2024), $2.5 million (Q4 2023), and $1.6 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 374.16 Bn |
| Dec 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 3,139.47 |
| Dec 31, 2020 | 3,404.49 |
| Dec 31, 2019 | 2,955.04 |
| Dec 31, 2018 | 310,397.00 |
| Dec 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | 615,948.78 |
| Jun 30, 2016 | 2.25 Mn |